this post was submitted on 04 Jan 2024
16 points (100.0% liked)

Health - Resources and discussion for everything health-related

3512 readers
81 users here now

Health: physical and mental, individual and public.

Discussions, issues, resources, news, everything.

See the pinned post for a long list of other communities dedicated to health or specific diagnoses. The list is continuously updated.

Nothing here shall be taken as medical or any other kind of professional advice.

Commercial advertising is considered spam and not allowed. If you're not sure, contact mods to ask beforehand.

Linked videos without original description context by OP to initiate healthy, constructive discussions will be removed.

Regular rules of lemmy.world apply. Be civil.

founded 2 years ago
MODERATORS
 

Drugmaker Eli Lilly on Thursday warned against using its diabetes and obesity drugs for “cosmetic” weight loss, as the medications have exploded in popularity, resulting in shortages.

In an open letter posted online, the company said its products Mounjaro and Zepbound “are indicated for the treatment of serious diseases; they are not approved for — and should not be used for — cosmetic weight loss.“

Lilly said it does not “promote or encourage” the use of any of its medicines outside of the approved indication. Neither Zepbound nor Mounjaro are approved for anyone who doesn’t have a diagnosis of obesity or Type 2 diabetes, among other weight-related conditions. The drugs are meant for long-term use to treat chronic conditions, not quick weight loss.

you are viewing a single comment's thread
view the rest of the comments
[–] RobotToaster@mander.xyz 2 points 2 years ago

Can't put the djinn back in the bottle